FMP
Feb 8, 2024 7:20 PM - Davit Kirakosyan(Last modified: Feb 9, 2024 1:15 AM)
CVS Health (NYSE:CVS) disclosed its fourth-quarter financial results and revised its earnings forecast for 2024 downwards.
In the fourth quarter of 2023, CVS Health announced an earnings per share (EPS) of $2.12, surpassing the analysts' consensus of $1.98. The company's revenue for the quarter was $93.81 billion, exceeding expectations of $90.25 billion.
Revenue from health services reached $49.15 billion, outperforming the anticipated $45.96 billion by analysts.
Looking into the full fiscal year of 2024, CVS Health adjusted its EPS forecast to a minimum of $8.30, a decrease from the previously projected $8.50. This adjustment comes in below the analyst consensus of $8.47.
Oct 31, 2023 8:03 AM - Parth Sanghvi
Free cash flow to the firm (FCFF) and free cash flow to equity (FCFE) are two of the most important metrics used in financial modeling. Both metrics measure the amount of cash that is available to a company's shareholders and creditors, but there is a key difference between the two. FCFF measures...
Nov 25, 2023 6:39 AM - Parth Sanghvi
Choosing the Right Valuation Method: DCF vs. Comparable Companies Analysis Introduction: Valuation methods play a pivotal role in determining the fair value of a company, aiding investors in making informed investment decisions. Two commonly used methods, DCF Valuation and Comparable Companies A...
Dec 23, 2023 2:19 AM - Parth Sanghvi
Introduction: Discounted Cash Flow (DCF) analysis stands as a cornerstone in valuing investments, yet its efficacy is contingent upon various assumptions and methodologies. While a powerful tool, DCF analysis comes with inherent limitations and challenges that investors must acknowledge to make i...